If the trial with Onyx is successful and Onyx shows significant interest, the sky will be the limit... Anywhere 50c+ is possible if a deal happens. But if it turns out to be a failure... It can quickly turn the other way too.
As mentioned in previous posts.. PAB's SM6 is THE ONLY MM antibody NOT tied up with a big pharma. It already received FDA & EU orphan drug status. all eyes will be on this trial with ONYX... Success might even attract other interest.. Celgene?
2014.... your thoughts and predictions, page-8
-
- There are more pages in this discussion • 56 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.172M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 35 | 24652453 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 25089307 | 16 |
View Market Depth
| Last trade - 16.12pm 11/10/2024 (20 minute delay) ? |
| PAB (ASX) Chart |
Day chart unavailable